Cerebral palsy diagnosis and management: The state of the art

Current Problems in Pediatric and Adolescent Health Care

Volumn 33, Issue 5, 2003, Pages 146-169

  Murphy, Nancy ^a   Such Neibar, Teresa ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CALCIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLONIDINE; CLORAZEPATE; DANTROLENE; DIAZEPAM; DOCUSATE SODIUM; GABAPENTIN; GLYCOPYRRONIUM BROMIDE; MACROGOL; MELATONIN; PHENOL; SCOPOLAMINE; TIZANIDINE; VITAMIN D;

ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; CEREBRAL PALSY; CHILD GROWTH; CHILD HEALTH CARE; CHILD HOSPITALIZATION; CHILD NUTRITION; CHILD REARING; CHOLINERGIC RECEPTOR BLOCKING; COMORBIDITY; CONSTIPATION; DECISION MAKING; DEPRESSION; DISEASE CLASSIFICATION; DORSAL RHIZOTOMY; DYSESTHESIA; EDEMA; EPIDEMIOLOGICAL DATA; FAMILY COUNSELING; FATIGUE; FLU LIKE SYNDROME; GESTATION PERIOD; HUMAN; HYPERBARIC OXYGEN; HYPERSALIVATION; HYPOTENSION; IRRITABILITY; LIFE EXPECTANCY; LIVER TOXICITY; MEDICAL EDUCATION; MEDICAL INFORMATION; MEMORY DISORDER; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PATHOGENESIS; PREMATURITY; PRESCRIPTION; PSYCHOSIS; REVIEW; RISK FACTOR; SEDATION; SLEEP DISORDER; SPASTICITY; TECHNICAL AID; URINE RETENTION; VISUAL IMPAIRMENT;

EID: 0038529461     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-5442(03)00002-6     Document Type: Review

References (141)

1. Nelson K, Russman B. Cerebral palsey. In: Swaiman K (ed). Pediatric Neurology. St. Louis, MO: Mosby Inc; 1994:471-488.
2. Blumenthal I. Cerebral palsy: medicolegal aspects. J Royal Soc Med 2001;94:624-7.
3. Longo LD, Ashwal S, Osler W., Sigmund Freud and the evolution of ideas concerning cerebral palsy. J Hist Neurosci 1993;2(4):255-82.
4. Badawi N, Watson L, Petterson B, Blair E, Slee J, Haan E, et al. What constitutes cerebral palsy? Dev Med Child Neurol 1998;40(8):520-7.
5. Perlman J. Neurobehavioral deficits in premature graduates of intensive care: potential and neonatal environmental risk factors. Pediatrics 2001;108(6):1339-48.
6. Nelson K, Grether J. Causes of cerebral palsy. Curr Opin Pediatr 1999;11(6):487-96.
7. Taft L. Cerebral palsy. Pediatr Rev 1995;16(11):411-8.
8. Bhushan V, Paneth N, Kiely J. Impact of improved survival of very low birth weight infants on recent secular trends in the prevalence of cerebral palsy. Pediatrics 1993;91(6):1094-100.
9. Pharoah P, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child 1996;75:F169-73.
10. Matthews D, Wilson P. Cerebral Palsy. In: Molnar G, Alexander M (eds). Pediatric Rehabilitation 3rd edition. Philadelphia: Hanley & Belfus, Inc; 1999:193-218.
11. Blair E, Stanley F. Interobserver agreement in the classification of cerebral palsy. Dev Med Child Neurol 1985;27(5): 615-22.
12. Sala DA, Grant AD. Prognosis for ambulation in cerebral palsy. Dev Med Child Neurol 1995;37(11):1020-6.
13. Nelson K, Ellenberg J. Antecedents of cerebral palsy. N Engl J Med 1986;135(2):81-6.
14. Nelson K, Ellenberg J. Antecedents of cerebral palsy. AJDC 1985;139:1031-38.
15. DeLucca P. The musculoskeletal management of children with cerebral palsy. Common Orthopedic Problems II 1996; 43(5):1135-51.
16. Pschirrer R, Yeomans E. Does asphyxia cause cerebral palsy? Semin Perinatol 2000;24(3):215-20.
17. Hoon A. Neuroimaging in the high risk infant: relationship to outcome. J Perinatol 1995;15(5):389-94.
18. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002;8(1):25-9.
19. Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983;103(2):273-7.
20. Han T, Bang M, Lim J, Yoon B, Kim I. Risk factors of cerebral palsy in preterm infants. Am J Phys Med Rehabil 2002;4:297-303.
21. Blair E, Stanley F. Issues in the classification and epidemiology of cerebral palsy. Ment Retard Dev Disabil Res Rev 1997;3(2):184-93.
22. Nelson KB, Ellenberg JH. Children who 'outgrew' cerebral palsy. Pediatrics 1982;69(5):529-36.
23. McMurray J, Wilson-Jones M, Khan J. Cerebral palsy and the NICU graduate. Neonatal Network 2002;21(1):53-7.
24. Blasco P. Primitive reflexes: their contribution to the early detection of cerebral palsy. Clin Pediatr 1994;33(7):388-97.
25. Lorenz J. The outcome of extreme prematurity. Semin Perinatol 2001;25(5):348-59.
26. Escobar G, Littenberg B, Petitti D. Outcome among surviving very low birthweight infants: a meta-analysis. Arch Dis Child 1990;66(2):204-11.
27. Dormans J, Pellegrino L. Caring for children with cerebral palsy. Baltimore, Md: Paul H. Brookes Publishing Co; 1998. p. 533.
28. Pediatrics AAP Red Book. 25th ed. L. Pickering. Vol. 2000, American Academy of Pediatrics.
29. Children With Disabilities Committee. The role of the pediatrician in prescribing therapy services for children with motor disabilities. Pediatrics 1996;98(2):308-10.
30. Toder D. Respiratory problems in the adolescent with developmental delay. Adolesc Med 2000; 11(3):617-31.
31. Menaker S, Batshaw M. In: Batshaw M, ed. Our window to the world. Baltimore: Brooks; 1997:211-240.
32. Zafeiriou D, Kontopoulos E, Tsikoulas I. Characteristics and prognosis of epilepsy in children with cerebral palsy. Epilepsy Cerebral Palsy 1999;14(5):289-93.
33. Fennell EB, Dikel TN. Cognitive and neuropsychological functioning in children with cerebral palsy. J Child Neurol 2001;16(1):58-63.
34. Horn E. Achieving meaningful motor skills: conceptual and empirical bases of a neurobehavioral. Ment Retard Dev Disabil 1997;3:138-44.
35. Butler C, Darrah J. Effects of neurodevelopmental treatment (NDT) for cerebral palsy: an AACPDM evidence report. Dev Med Child Neurol 2001;43:778-90.
36. Children With Disabilities Committee. The treatment of neurologically impaired children using patterning. Pediatrics 1999;104(5):1149-51.
37. Robinson RO, McCarthy GT, Little TM. Conductive education at the Peto Institute, Budapest. BMJ 1989;299:1145-7.
38. Reddihough DS, King J, Coleman G, Catanese T. Efficacy of programs based on conductive education for young children with cerebral palsy. Dev Med Child Neurol 1998;40(11): 763-70.
39. Hardy P, Collet JP, Goldberg J, Ducruet T, Vanasse M, Lambert J, et al. Neuropsychological effects of hyperbaric oxygen therapy in cerebral palsy. Dev Med Child Neurol 2002;44:436-46.
40. American Academy for CP and Developmental Medicine, United Cerebral Palsy Research and Educational Foundation, United CP Association. Status Report on Unsubstantiated Interventions. Present Status of Hyperbaric Oxygen Therapy for The Treatment of Cerebral Palsy. 1999.
41. Nuthall G, Seear M, Lepawsky M, Wensley D, Skippen P, Hukin J. Hyperbaric oxygen therapy for cerebral palsy: two complications of treatment. Pediatrics 2000;106(6):E80.
42. Heuser G, Uszler JM. Hyperbaric oxygenation for cerebral palsy. Lancet 2001;357(9273):2053-4.
43. Paul-Collet J, Marois P, Amar M, Goldberg J, Lambert J, Lassonde M, et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre. Lancet 2001;357: 582-6.
44. Crocker MD, MacKay-Lyons M, McDonnell E. Forced use of the upper extremity in cerebral palsy: a single-case design. Am J Occup Ther 1997;51(10):824-33.
45. Willis JK, Morello A, Davie A, Rice JC, Bennett JT. Forced use treatment of childhood hemiparesis, Pediatrics 2002; 110(1 Pt 1):94-6.
46. Helsl P, McGee J, Graveline C. Physical Management of Spasticity. Physical Management of Spasticity 2001;16(1): 24-30.
47. Palmer F. Evaluation of developmental therapies in cerebral palsy. Ment Retard Dev Disabil Res Rev 1997;3(2):145-52.
48. Hur JJ. Review of research on therapeutic interventions for children with cerebral palsy. Acta Neurol Scand 1995;91: 423-32.
49. Msall M, Rogers BT, Ripstein H, Lyon N, Wilczenski F. Measurements of functional outcomes in children with cerebral palsy. Ment Retard Dev Disabil Res Rev 1997;3(2):194-203.
50. Fuhrer MJ. Conference report: an agenda for medical rehabilitation outcomes research. J Allied Health 1995;24(1):79-87.
51. Binder H, Eng G. Rehabilitation management of children with spastic diplegic cerebral palsy. Arch Phys Med Rehabil 1989;70:482-7.
52. Solomon R. Pediatricians and early intervention: Everything you need to know but are too busy to ask. Infants and Young Children 1995;7(3):39-51.
53. Baird G, McConachie H, Scrutton D. Parents' perceptions of disclosure of the diagnosis of cerebral palsy. Arch Dis Child 2000;83(6):475-80.
54. Reilly SM, Skuse DH, Wolke D, Stevenon J. Oral-motor dysfunction in children who fail to thrive: organic or non-organic? Dev Med Child Neurol 1999;41:115-22.
55. Chong S. Gastrointestinal problems in the handicapped child. Curr Opin Pediatr 2001;13:411-46.
56. Eltumi M, Sullivan PB. Nutritional management of the disabled child: the role of percutaneous endoscopic gastrostomy. Dev Med Child Neurol 1997;39(1):66-8.
57. Cronk C, Stallings V. Growth in children with cerebral palsy. Ment Retard Dev Disabil 1997;3:129-37.
58. Stevenson R, Roberts C, Vogtle L. The effects of non-nutritional factors on growth in cerebral palsy. Dev Med Child Neurol 1995;37:124-30.
59. Motion S, Northstone K, Emond A, Stucke S, Golding J. Early feeding problems in children with cerebral palsy: weight and neurodevelopmental outcomes. Dev Med Child Neurol 2002;44(1):40-3.
60. Smith SW, Camfield C, Camfield P. Living with cerebral palsy and tube feeding: a population-based follow-up study. J Pediatr 1999;135(3):307-10.
61. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000;118(1):7-13.
62. Wales PW, Diamond IR, Dutta S, Muraca S, Chait P, Connolly B, et al. Fundoplication and gastrostomy versus image-guided gastrojejunal tube for enteral feeding in neurologically impaired children with gastroesophageal reflux. J Pediatr Surg 2002;37(3):407-12.
63. Mayo M. Lower urinary tract dysfunction in cerebral palsy. J Urol 1992;147:419-20.
64. Roijen LEG, Postema K, Limbeek J, Kuppevelt HJM. Development of bladder control in children and adolescents with cerebral palsy. Dev Med Child Neurol 2001;43: 103-7.
65. Condie DN. Conclusions and recommendations. In: Condie DN, Meadows CB (eds). Report of a consensus conference on the lower limb orthotic management of cerebral palsy. Copenhagen, Denmark: International Society for Prosthetics and Orthotics; 1995:1-20.
66. Zucconi M, Bruni O. Sleep disorders in children with neurologic diseases. Semin Pediatr Neurol 2001;8(4):258-75.
67. Shibagake M, Kiyono S, Takeuchi T. Electroencephalography. Clin Neurophysiol 1985;61:465-71.
68. Tanaka H, Araki A, Ito J, Tasaki T, Miyamoto A, Cho K. Improvement of hypertonus after treatment for sleep disturbances in three patients with severe brain damage. Brain Dev 1997;19(4):240-4.
69. McCarty SF, Gaebler-Spira D, Harvey RL. Improvement of sleep apnea in a patient with cerebral palsy. Am J Phys Med Rehabil 2001;80(7):540-2.
70. Nickel RE. Developmental delay and mental retardation. In: Nickel RE, Desch, eds. The physician's guide to caring for children with disabilities and chronic conditions. Baltimore, MD: Brooks; 2000:111.
71. Jan JE, Freeman RD, Fast DK. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev Med Child Neurol 1999;41(7):491-500.
72. Siegel L, Klingbeil M. Control of drooling with transdermal scopolamine in a child with cerebral palsy. Dev Med Child Neurol 1991;33:1010-4.
73. Thomas-Stonell A, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988;3:73-8.
74. Lewis D, Fontana C, Mehallick L, Everett Y. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 1994;36:484-6.
75. Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, et al. Botulinum toxin as a treatment for excessive drooling in children. Pediatr Neurol 2002;27(1): 18-22.
76. Suskind D, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
77. Geralis E. Children with cerebral palsy: a parents guide. Bethesda, Md: Woodbine House; 1998.
78. Injury and Poison Prevention Co. School bus transportation of children with special health care needs. Pediatrics 2001; 108(2):516-8.
79. DiGaudio K, Msall M. Guidelines for safe transportation of children in wheelchairs. AJDC 1991;145:653-5.
80. Glasscock R. A phenomenological study of the experience of being a mother of a child with cerebral palsy. Pediatr Nurs 2000;26(4):407-10.
81. Curran AL, Sharples PM, White C, Knapp M. Time costs of caring for children with severe disabilities compared with caring for children without disabilities. Dev Med Child Neurol 2001;43(8):529-33.
82. Lobato D, Barbour L, Miller C, Hall L, Pezzullo J. Preschool siblings of handicapped children: interactions with mothers, brothers and sisters. Res Dev Disabil 1991;12:387-99.
83. Krach L. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol 2001;16(1):31-5.
84. Brunstrom J. Clinical considerations in cerebral palsy and spasticity. J Child Neurol 2001;16:10-5.
85. Tilton AH, Maria BL, editors. Consensus statement on pharmacotherapy for spasticity. J Child Neurol 2001;16(1): 66-7.
86. Goldstein E. Spasticity management: an overview. J Child Neurol 2001;16:16-23.
87. Gormley M. Treatment of neuromuscular and musculoskeletal problems in cerebral palsy. Pediatr Rehabil 2001;4(1): 5-16.
88. Edgar T. Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review. J Child Neurol 2001;16(1):37-46.
89. Leach J. Children undergoing treatment with botulinum toxin: the role of the physical therapist. Muscle Nerve 1997;(Suppl 6):S194-207.
90. Katz RT. Management of spasticity. Am J Phys Med Rehabil 1988:67(3):108-16.
91. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 2000;42:634-45.
92. Davidoff R. Antispasticity drugs: mechanisms of action. Ann Neurol 1985;17(2):107-16.
93. Albright AL. Spastic cerebral palsy. CNS Drugs 1995;4(1): 17-27.
94. Stempien L, Gaebler-Spira D. Physical Medicine and Rehabilitation. In: Braddom RL, ed. Rehabilitation of Children and Adults With Cerebral Palsy. Philadelphia, PA: WB Saunders; 1996. p. 1113-2.
95. Boop FA, Woo R, Maria BL. Consensus statement on the surgical management of spasticity related to cerebral palsy. J Child Neurol 2001;16(1):68-9.
96. Wright V, Sheil E, Drake J, Wedge J, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol 1998;40:239-47.
97. Morton R. New surgical interventions for cerebral palsy and the place of gait analysis. Dev Med Child Neurol 1999;41: 424-8.
98. McLaughlin JF, Bjornson KF, Temkin N, Steinbok P, Wright V, Reiner A, et al. Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol 2002;44:17-25.
99. Craft S, Park TS, White DA, Schatz J, Noetzel M, Arnold S. Changes in cognitive performance in children with spastic diplegic cerebral palsy following selective dorsal rhizotomy. Pediatr Neurosurg 1995;23(2):68-75.
100. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity. Am J Phys Med Rehabil 2000;79(6):536-41.
101. Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. Neurol Neurosurg Psychiatry 1997;63:204-9.
102. Murphy N, Irwin M, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil 2002; 83(12):1721-5.
103. Green L, Nelson V. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 1999;80:1600-3.
104. Coffey R, Edgar T, Francisco G, Graziani V, Meythaler J, Ridgely P, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life threatening syndrome. Arch Phys Med Rehabil 2002;83: 735-9.
105. Sherk H, Pasquariello P, Doherty J. Hip dislocation in cerebral palsy: selection for treatment. Dev Med Child Neurol 1983;25:738-46.
106. Lonstein J, Beck K. Hip dislocation and subluxation in cerebral palsy. J Pediatr Orthop 1986;6:521-6.
107. Black B, Griffin P. The cerebral palsied hip. Clin Orthop Rel Res 1997;338:42-51.
108. Woo R. Spasticity: orthopedic perspective. J Child Neurol 2001;16:47-53.
109. Hodgkinson I, Jindrich ML, Duhaut P, Vadot JP, Metton G, Berard C. Hip pain in 234 non-ambulatory adolescents and young adults with cerebral palsy: a cross-sectional multicentre study. Dev Med Child Neurol 2001;43:806-8.
110. Pritchett J. Treated and untreated unstable hips in severe cerebral palsy. Dev Med Child Neurol 1989;32:3-6.
111. King G, Cathers T, Polgar J, MacKinnon E, Havens L. Success in life for older adolescents with cerebral palsy. Qual Health Res 2000;10(6):734-49.
112. Gordon N. Startle disease or hyperekplexia. Dev Med Child Neurol 1993;35(11):1015-8.
113. Magill-Evans J, Darrah J, Pain K, Adkins R, Kratochvil M. Are families with adolescents and young adults with cerebral palsy the same as other families? Dev Med Child Neurol 2001;43(7):466-72.
114. Magill-Evans JE, Restall G. Self-esteem of persons with cerebral palsy: from adolescence to adulthood. Am J Occup Ther 1991;45(9):819-25.
115. O'Grady R, Crain L, Kohn J. The prediction of long-term functional outcomes of children with cerebral palsy. Dev Med Child Neurol 1995;37:997-1005.
116. Child Abuse and Neglect Committee, Children With Disabilities Committee. Assessment of maltreatment of children with disabilities. Pediatrics 2001;108(2):508-12.
117. Blanck P, Schmeling J. Americans With Disabilities Act: recent and pending U.S. Supreme Court decisions and implications for spine professionals. Spine 2001;27(4):439-43.
118. Schwartz L, Engel J, Jensen M. Pain in persons with cerebral palsy. Arch Dis Child 1999;80:1243-5.
119. Thomson J, Banta J. Scoliosis in cerebral palsy: an overview and recent results. J Pediatr Orthop Part B 2001;10(6):6-9.
120. Winter S. Preoperative assessment of the child with neuromuscular scoliosis. Orthop Clin North Am 1994;25(2):239-45.
121. Saito N, Ebara S, Ohotsuka K, Kumeta H. Natural history of scoliosis in spastic cerebral palsy. Lancet 1998;351:1687-92.
122. Miller A, Temple T, Miller F. Impact of orthoses on the rate of scoliosis progression in children with cerebral palsy. J Pediatr Orthop 1996;16:332-5.
123. Terjesen T, Lange J, Steen H. Treatment of scoliosis with spinal bracing in quadriplegic cerebral palsy. Dev Med Child Neurol 2000;42:448-54.
124. Leopando T, Moussavi Z, Holbrow J, Chernick V, Pasterkamp H, Rempel G. Effect of a soft boston orthosis on pulmonary mechanics in severe cerebral palsy. Pediatr Pulmonol 1999;28:53-8.
125. Comstock C, Leach J, Wenger D. Scoliosis in total body involvement cerebral palsy. Spine 1998;23:1412-25.
126. Jevslvar D, Karlin L. The relationship between preoperative nutritional status and complications after an operation for scoliosis in patients who have cerebral palsy. J Bone Joint Surg 1993;75-A(6):880-4.
127. Sterba JA, Rogers BT, France AP, Vokes DA. Horseback riding in children with cerebral palsy: effect on gross motor function. Dev Med Child Neurol 2002;44(5):301-8.
128. Durstine L, Painter P, Franklin B, Morgan D, Piteeti K, Roberts S. Physical activity for the chronically ill and disabled. Sports Med 2000;30(3):207-19.
129. Rimmer J. Physical fitness levels of persons with cerebral palsy. Dev Med Child Neurol 2001;43(3):147.
130. Brunner R, Doderlein L. Pathological fractures in patients with cerebral palsy. J Pediatr Orthop B 1996;5(4):232-8.
131. Henderson R, Lark R, Gurka M, Worley G, Fung EB, Conaway M, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002;110(1):e5.
132. Tasdemir H, Buyukavci M, Akcay F, Polat P, Yildiran A, Karakelleoglu C. Bone mineral density in children with cerebral palsy. Pediatr Int 2001;43:157-60.
133. Bischof F, Basu D, Pettifor JM. Pathological long-bone fractures in residents with cerebral palsy in a long-term care facility in South Africa. Dev Med Child Neurol 2002;44:119-22.
134. Jekovec-Vrhovsek M, Kocijancic A, Prezelj J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol 2000;42(6):403-5.
135. Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 1999;135(1): 115-7.
136. Strauss D, Shavelle R. Life expectancy of adults with cerebral palsy. Dev Med Child Neurol 1998;40:369-75.
137. Hutton J, Cooke T, Pharoah P. Life expectancy in children with cerebral palsy. BMJ 1994;309:431-5.
138. Williams K, Alberman E. Survival in cerebral palsy: the role of severity and diagnostic labels. Dev Med Child Neurol 1998;40:376-9.
139. Sneed R, May W, Stencel C. Training of pediatricians in care of physical disabilities in children with special health needs: results of a two state survey of practicing pediatricians and national resident training programs. Pediatrics 2000;105(3): 554-61.
140. Dosa N, Boeing N, Kanter R. Excess risk of severe acute illness in children with chronic health conditions. Pediatrics 2001;107(3):499-503.
141. Liptak G, O'Donnell M, Conaway M, Chumlea W, Worley G, Henderson RC, et al. Health status of children with moderate to severe cerebral palsy. Dev Med Child Neurol 2001;43:364-70.